Company Filing History:
Years Active: 2019-2025
Title: Oleksandr Shvets: Innovator in Diabetes Management
Introduction
Oleksandr Shvets is a notable inventor based in Everett, WA (US). He has made significant contributions to the field of diabetes management through his innovative patents. With a total of 3 patents, his work focuses on improving insulin administration and patient safety.
Latest Patents
One of his latest patents is an "Insulin titration algorithm based on patient profile." This invention provides a device, system, and method for predicting the risk of hypoglycemia and adjusting insulin dosage for patients on pen-based multi-daily injections. The algorithm computes an initial insulin dose based on timestamped blood glucose measurements and previously injected doses. A risk prediction module utilizes machine learning to assess hypoglycemia risk and recommends an adjusted insulin dose to maintain a non-hypoglycemic state.
Another significant patent is the "System for providing an up-to-date and long-acting or ultra-long-acting insulin dose guidance recommendation to treat diabetes mellitus." This invention outlines a novel administration regime for long-acting or ultra-long-acting insulin, which is beneficial for treating conditions requiring insulin. The system involves collecting various data sets and structures from the subject to provide accurate insulin dose guidance.
Career Highlights
Oleksandr Shvets is currently employed at Novo Nordisk A/S, a leading company in diabetes care. His work at Novo Nordisk has allowed him to focus on developing innovative solutions that enhance patient outcomes in diabetes management.
Collaborations
He collaborates with talented professionals in the field, including Thomas Dedenroth Miller and Anuar Imanbayev. These collaborations contribute to the advancement of diabetes treatment technologies.
Conclusion
Oleksandr Shvets is a pioneering inventor whose work in diabetes management is making a significant impact. His innovative patents and contributions to Novo Nordisk A/S highlight his commitment to improving patient care and safety in insulin administration.